NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/13/2024
Back to search
Official data from USPTO
CREDO DIAGNOSTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
41
Latest update
08/13/2024
Trademark type
Combined
Nice classes
1, 5, 9, 10
Filing date
02/25/2020
Registration date
08/13/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/13/2024
Last transaction
08/13/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
01/06/2020
First use in commerce
03/18/2021
Drawing code
3
Owner type
99
Owner location
Singapore, SG
Examiner
YI, CRYSTAL HAEIN
Law office
N50
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized words "CREDO DIAGNOSTICS", with the "O" in "CREDO" forming a drop with a looping curved band inside.
Holders and representatives
Holders
Credo Diagnostics Biomedical Pte. Ltd.
Representatives
Paulo A. de Almeida PATEL & ALMEIDA, P.C.
Technical classification
Nice Classes
Class 1Class 5Class 9Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Enzymes for industrial purposes
Class 5
Diagnostic preparations for veterinary purposes; Enzyme preparations for medical purposes; Diagnostic preparations for medical purposes; Enzyme preparations for veterinary purposes; Enzymes for veterinary purposes
Class 9
Apparatus for physicsapparatus for measuring nucleic acid or proteins for in vitro diagnostic use not for medical purposes; Instruments for physicsinstruments for qualifying or quantifying nucleic acid or proteins for in vitro diagnostic use not for medical purposes; Monitoring apparatusother than for medical purposesfor monitoring nucleic acid or proteins for in vitro diagnostic use; Chemistry instrumentsinstruments for amplifying genes for in vitro diagnostic use not for medical purposes; Chemistry apparatusapparatus for extracting nucleic acid or proteins for in vitro diagnostic use not for medical purposes; Test tubes; Precision measuring apparatusnucleic acid or protein measuring apparatus for in vitro diagnostic use not for medical purposes
Class 10
Veterinary apparatus and instrumentsin vitro diagnostic veterinary apparatus and instruments for measuring nucleic acids or proteins; Diagnostic apparatus for medical purposes for testing nucleic acid or proteins for in vitro diagnostic use; All of the foregoing goods excluding insulatedrefrigeratedtemperature controlled containerscasesboxescartons
Publications
History of USPTO decisions and trademark events.
41 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
08/13/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
07/10/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
07/10/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
07/08/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
07/08/2024
IUAF
USE AMENDMENT FILED
05/30/2024
EISU
TEAS STATEMENT OF USE RECEIVED
05/30/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
02/13/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/19/2023
PUBO
PUBLISHED FOR OPPOSITION
12/19/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/29/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/15/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/15/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/15/2023
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
10/31/2023
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
05/17/2023
GNSL
LETTER OF SUSPENSION E-MAILED
05/17/2023
CNSL
SUSPENSION LETTER WRITTEN
05/17/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/16/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/15/2023
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
05/15/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
11/18/2022
GNFR
FINAL REFUSAL E-MAILED
11/18/2022
CNFR
FINAL REFUSAL WRITTEN
11/18/2022
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
05/10/2022
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
11/10/2021
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
05/13/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
11/13/2020
GNSL
LETTER OF SUSPENSION E-MAILED
11/13/2020
CNSL
SUSPENSION LETTER WRITTEN
11/13/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/12/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/12/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/12/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/14/2020
GNRT
NON-FINAL ACTION E-MAILED
05/14/2020
CNRT
NON-FINAL ACTION WRITTEN
05/14/2020
DOCK
ASSIGNED TO EXAMINER
05/13/2020
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
03/05/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/04/2020
NWAP
NEW APPLICATION ENTERED
02/28/2020
Continuous trademark protection
Get notified about every new filing that threatens CREDO DIAGNOSTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.